Attovia Therapeutics, Inc.
Biotechnology Research (clinical-stage biopharmaceutical company) · San Carlos, CA
S-1 FiledATTO
Attovia Therapeutics, Inc. IPO
Monitoring
S-1 Filed
Priced
Trading
Est. valuation
$100M
Exchange
—
Ticker: ATTO
Status
S-1 Filed
Filed
Jul 14, 2026
IPO timeline
Jul 14, 2026
S-1 filed with SEC
Initial registration statement submitted to the Securities and Exchange Commission.
Upcoming
Roadshow & pricing
Company presents to institutional investors. IPO price and share count are finalized.
Upcoming
First-day trading
Shares available on the open market.
Frequently asked questions
When is Attovia Therapeutics, Inc. going public?
Attovia Therapeutics, Inc. has not yet announced an IPO date or filed a registration statement with the SEC. FireStrike will update this page when official filings or announcements are made.
What is Attovia Therapeutics, Inc.'s IPO valuation?
The estimated offering value is $100M. Final valuation will be determined at pricing.
What exchange will Attovia Therapeutics, Inc. list on?
No exchange has been officially announced for the Attovia Therapeutics, Inc. IPO.
Has Attovia Therapeutics, Inc. filed an S-1 with the SEC?
No. As of the most recent data, Attovia Therapeutics, Inc. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR